|
Model Number RSINT35022X |
Device Problem
Activation, Positioning or Separation Problem (2906)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 02/15/2024 |
Event Type
malfunction
|
Manufacturer Narrative
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Event Description
|
An attempt was made to use one resolute integrity coronary drug eluting stent to treat 90% stenosis in the proximal left anterior descending (lad) artery.The device was inspected with no issues.The lesion was pre-dilated.The device did not pass through a previously-deployed stent.Resistance was not encountered when advancing the device.Excessive force was not used during delivery.It was reported that the stent failed to expand.The stent was not implanted.No patient injury was reported.
|
|
Manufacturer Narrative
|
Additional information: there was partial inflation of the balloon.An inflation pressure of 9 atm was applied.Inflation difficulties were not encountered.The same inflation device was successfully used with other devices.There was no injury to the patient as a result of the event.Image analysis: one photo was received from the account.The image appears to show a resolute integrity device coiled in a hoop laying on a shelf carton.The information on the label of the shelf carton matches what was reported on file.The complaint cannot be confirmed from the still image provided by the account.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Manufacturer Narrative
|
Product analysis summary: the device returned with balloon folds intact and passed negative prep.The balloon was inflated to 9 atm and maintained pressure and the stent expanded with no issues noted.No other deformation was evident to the remainder of the device.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Search Alerts/Recalls
|
|
|